Angus Lau

Mr. Angus Lau

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2019 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
ALAngus Lau
Angus Lau
RSRaphaella W. L. So
Raphaella W. L. So
HLHeather H. C. Lau
Heather H. C. Lau
JSJason C. Sang
Jason C. Sang
ARAlejandro Iván Ruiz Riquelme
Alejandro Iván Ruiz Riquelme
JWJoel C. Watts
Joel C. Watts

1 November 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
ALAngus Lau
Angus Lau
IBIman Beheshti
Iman Beheshti
MMMandana Modirrousta
Mandana Modirrousta
TKTiffany Kolesar
Tiffany Kolesar
AGAndrew L. Goertzen
Andrew L. Goertzen
JKJi Hyun Ko
Ji Hyun Ko
Dementia is broadly characterized by cognitive and psychological dysfunction that significantly impairs daily functioning. Dementia has many causes including Alzheimer’s disease (AD), dementia with Lewy bodies (DLB), and frontotemporal lobar degeneration (FTLD). Detection and differential diagnosis in the early stages of dementia remains challenging. Fueled by AD Neuroimaging Initiatives (ADNI) (Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database. As such, the investigators within ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report.), a number of neuroimaging biomarkers for AD have been proposed, yet it remains to be seen whether these markers are also sensitive to other types of dementia. We assessed AD-related metabolic patterns in 27 patients with diverse forms of dementia (five had probable/possible AD while others had atypical cases) and 20 non-demented individuals. All participants had positron emission tomography (PET) scans on file. We used a pre-trained machine learning-based AD designation (MAD) framework to investigate the AD-related metabolic pattern among the participants under study. The MAD algorithm showed a sensitivity of 0.67 and specificity of 0.90 for distinguishing dementia patients from non-dementia participants. A total of 18/27 dementia patients and 2/20 non-dementia patients were identified as having AD-like patterns of metabolism. These results highlight that many underlying causes of dementia have similar hypometabolic pattern as AD and this similarity is an interesting avenue for future research.

16 October 2017 in Discoveries
Verified
Journal Article
Open access
ALAngus Lau
Angus Lau
MBMatthew Bourkas
Matthew Bourkas
YLYang Qing Qin Lu
Yang Qing Qin Lu
LOLauren Anne Ostrowski
Lauren Anne Ostrowski
DWDanielle Weber-Adrian
Danielle Weber-Adrian
Gerold Schmitt-UlmsGerold Schmitt-Ulms
Gerold Schmitt-Ulms
Amyloids play critical roles in human diseases but have increasingly been recognized to also exist naturally. Shared physicochemical characteristics of amyloids and of their smaller oligomeric building blocks offer the prospect of molecular interactions and crosstalk amongst these assemblies, including the propensity to mutually influence aggregation. A case in point might be the recent discovery of an interaction between the amyloid β peptide (Aβ) and somatostatin (SST). Whereas Aβ is best known for its role in Alzheimer disease (AD) as the main constituent of amyloid plaques, SST is intermittently stored in amyloid-form in dense core granules before its regulated release into the synaptic cleft. This review was written to introduce to readers a large body of literature that surrounds these two peptides. After introducing general concepts and recent progress related to our understanding of amyloids and their aggregation, the review focuses separately on the biogenesis and interactions of Aβ and SST, before attempting to assess the likelihood of encounters of the two peptides in the brain, and summarizing key observations linking SST to the pathobiology of AD. While the review focuses on Aβ and SST, it is to be anticipated that crosstalk amongst functional and disease-associated amyloids will emerge as a general theme with much broader significance in the etiology of dementias and other amyloidosis.

10 May 2018
Verified
Book Chapter
Closed access
PDF file
HLHeather H. C. Lau
Heather H. C. Lau
ALAngus Lau
Angus Lau
JWJoel C. Watts
Joel C. Watts